Asset Allocation & Management Company, LLC Bristol Myers Squibb CO Transaction History

Asset Allocation & Management Company, LLC

$151 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $107,582 - $127,392	-1,571 Reduced 27.5%	4,142 $298,000
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $622,280 - $685,348	-8,569 Reduced 60.0%	5,713 $440,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $765,943 - $892,910	14,282 New	14,282 $890,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Allocation & Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Allocation & Management Company, LLC with notifications on news.

Account